The specific aims capitalize on advances in -omics, cancer biology, and cancer imaging to further the development, testing, and implementation of primary, secondary, and tertiary cancer prevention strategies in diverse populations:
- Aim 1. Advance understanding of the biological, behavioral, environmental and geospatial determinants that shape cancer risk, progression and survivorship.
We aim to provide insights into how biological mechanisms, individual behaviors, environmental exposures and geospatial contexts interact to influence cancer risk, disease progression and survivorship outcomes, thereby identifying actionable pathways to reduce cancer burden across all populations.
- Aim 2. Develop, implement, and rigorously evaluate evidence-based interventions that improve outcomes across the cancer control continuum from prevention through detection, diagnosis and survivorship.
We aim to develop, implement and rigorously evaluate evidence-based interventions that improve outcomes across the cancer control continuum. By generating scalable and sustainable strategies, this research directly accelerates translation of research into measurable population impact.
